Updates are available Correction dated 2024-10-07
Click to view Correction: https://doi.org/10.1038/s41391-024-00902-3
-
Authors
Matsukawa, Akihiro https://orcid.org/0000-0002-3324-762X
Yanagisawa, Takafumi https://orcid.org/0000-0002-7410-0712
Parizi, Mehdi Kardoust
Laukhtina, Ekaterina https://orcid.org/0000-0002-8953-0272
Klemm, Jakob
Fazekas, Tamás
Mori, Keiichiro
Kimura, Shoji
Briganti, Alberto
Ploussard, Guillaume
Karakiewicz, Pierre I.
Miki, Jun
Kimura, Takahiro https://orcid.org/0000-0002-5673-1553
Rajwa, Pawel https://orcid.org/0000-0003-4073-6584
Shariat, Shahrokh F. https://orcid.org/0000-0002-6627-6179
- License Information
-
More Information
Article History
Received: 24 April 2024
Revised: 30 June 2024
Accepted: 19 August 2024
First Online: 5 September 2024
Change Date: 7 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41391-024-00902-3
Competing interests
: TK is a paid consultant/advisor of Astellas, Bayer, Janssen and Sanofi. SFS received follows: Honoraria: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, Takeda Consulting or Advisory Role: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, Takeda Speakers Bureau: Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, Takeda. PR is a paid consultant/advisor of Janssen. The other authors declare no conflicts of interest associated with this manuscript.
